Interleukin-7 (IL-7) is an essential T-cell survival cytokine. IL-7 receptor (IL-7Ra) deficiency severely impairs T-cell development due to substantial apoptosis. We hypothesized that IL-7Ra null -induced apoptosis is partially contributed by an elevated p53 activity. To investigate the genetic association of IL-7/IL-7Ra signaling with the p53 pathway, we generated IL-7Ra null p53 null (DKO) mice. DKO mice exhibited a marked reduction of apoptosis in developing T cells and an augmented thymic lymphomagenesis with telomere erosions and exacerbated chromosomal anomalies, including chromosome duplications, breaks, and translocations. In particular, Robertsonian translocations, in which telocentric chromosomes fuse at the centromeric region, and a complete loss of telomeres at the fusion site occurred frequently in DKO thymic lymphomas. Cellular and molecular investigations revealed that IL-7/IL-7Ra signaling withdrawal diminished the protein synthesis of protection of telomere 1 (POT1), a subunit of telomere protective complex shelterin, leading to telomere erosion and the activation of the p53 pathway. Blockade of IL-7/IL-7Ra signaling in IL-7-dependent p53 null cells reduced POT1 expression and caused telomere and chromosome abnormalities similar to those observed in DKO lymphomas. This study underscores a novel function of IL-7/IL-7Ra during T-cell development in regulating telomere integrity via POT1 expression and provides new insights into cytokinemediated survival signals and T-cell lymphomagenesis. Interleukin-7 (IL-7) is an essential and nonredundant cytokine for T-cell development.
Interleukin-7 (IL-7) is an essential and nonredundant cytokine for T-cell development. 1 Humans and mice deficient in IL-7 receptor (IL-7Ra) incur severe T-cell development defects, manifesting SCID. [1] [2] [3] [4] Early studies have shown that unbalanced survival signals of the Bcl-2 family members contribute to the impaired thymopoiesis in IL-7Ra deficiency. 1 Nevertheless, ectopic expression of Bcl-2 or inactivation of Bcl-2-associated X protein in IL-7Ra null mice only partially rescues the thymopoietic defect, [5] [6] [7] suggesting the possible involvement of the other pathways.
The tumor-suppressor p53 is a crucial transcription factor in controlling the cell cycle and apoptosis of cells under genotoxic stresses. 8 Early studies show that p53 participates in critical thymopoiesis checkpoints related to T-cell receptor rearrangement and DNA damage repair. [9] [10] [11] Emerging evidence suggests that p53 is a crucial regulatory factor of normal physiological processes, such as maintenance of stem cell state, development, tissue homeostasis, and autoimmunity. [12] [13] [14] [15] We hypothesized that p53 activation also contributes to the apoptosis and impaired thymopoiesis in IL-7Ra deficiency. However, the interplay between the IL-7/IL-7Ra signaling and the p53 pathway has not been demonstrated.
To decipher the potential genetic association of the IL-7Ra signaling with the p53 pathway, we crossed IL-7Ra null mice with p53 null mice. Intriguingly, genetic deletion of p53 in IL-7Ra null background (IL-7Ra null p53 null , DKO mice) not only markedly reduced the apoptosis of developing T cells, but also significantly increased the incidence and accelerated the onset of thymic lymphoma compared with p53 null mice. Furthermore, p53 inactivation permitted the survival of IL-7Ra null thymocytes that incurred telomere dysfunction and encouraged chromosome instability, leading to exacerbated lymphomagenesis in DKO mice. Additionally, we demonstrated that IL-7/IL-7Ra signaling has a crucial role in maintaining telomere integrity and genomic stability during thymopoiesis by regulating the expression of protection of telomere 1 (POT1), a crucial component of telomere protective complex shelterin.
Results

Thymopoiesis defect in IL-7Ra
null mice is associated with a marked increased in p53 activity. IL-7Ra deficiency results in a 99% to 99.9% reduction in thymic cellularity. 4 Besides the documented imbalance of pro-survival and proapoptotic signals of the Bcl-2 family members, [4] [5] [6] [7] we postulated that elevated p53 activity also contributes to the thymopoietic defect in IL-7Ra null mice. Our immunofluorescence staining for p53 confirmed a preferential increase in the percentage of p53-positive thymocytes in IL-7Ra null mice as compared with those in wild-type (WT) and p53 null mice ( Figure 1a ). Because p53 phosphorylation is associated with its activation, 16 we determined its levels. Indeed, phosphorylation of p53 at serines 23 (p53Ser 23 ) and 18 (p53Ser 18 ) in the thymocytes of IL-7Ra null mice was markedly increased as compared with those of WT and p53 null mice (Figure 1b ). This enhanced p53 activity in IL-7Ra null thymocytes was confirmed as marked upregulation of p53 downstream targets, such as p53 upregulated modulator of apoptosis (puma) and p21, by western blotting and quantitative RT-PCR (Figures 1b and c) . Similarly, an increase in Bcl-2-associated X protein mRNA with a concurrent reduction in Bcl2 mRNA in IL-7Ra null thymocytes was also observed (Figure 1c) . To determine the thymocyte subsets that incurred elevated p53 activity, we employed intracellular staining of p53Ser 18 Figure S1A) . Consistent with a previous report, 9 p53 was not activated in the thymi of Rag1 null mice whose impaired thymopoiesis was caused by a failure to initiate T-cell receptor rearrangement (Supplementary Figure S1B) . Together, these results suggest that the activated p53 pathway is a specific contributing factor to the impaired thymopoiesis in IL-7Ra null mice. (Figure 2a) . The cellularity of all four pro-T subsets, DN1 to DN4, was markedly increased in DKO mice, although those of CD44 þ 25 À (DN1) and CD44 À 25 þ (DN3) were more profound (Figure 2b ). Because all p53 null mice succumbed to tumorigenesis and died within 40 weeks with a median survival of 23 weeks (Figure 2c) , 17 
þ DP thymocytes (Figure 2d ). Interestingly, close to 60% of thymic lymphomas in DKO mice disseminated systemically to both lymphoid, such as the spleen and lymph nodes, and non-lymphoid tissues, such as the liver and kidneys, whereas only 13% of the tumors from p53 null mice showed limited dissemination to the lymphoid but not non-lymphoid tissues (Figure 2e and Supplementary Table 2 ). FACS analysis further confirmed thymic origin of the disseminated tumors in DKO mice (Figure 2e) . These results clearly demonstrate that inactivation of p53 partially, but markedly, restored the thymopoiesis defects of IL-7Ra null with the dire consequence of augmented thymic lymphomagenesis. Our study provides direct evidence of the functional interplay between IL-7Ra signaling and the p53 pathway during thymopoiesis.
Thymic lymphomas in DKO mice incur exacerbated genomic instability. Genomic instability, such as aneuploidy and translocation, is a hallmark and potential cause of tumorigenesis. 18, 19 To investigate whether the augmented lymphomagenesis and enhanced dissemination in DKO mice were associated with increased genomic instability, we performed DNA content analysis via FACS. Fresh thymic lymphomas from p53 null mice contained aneuploid and polyploid (44n, Figure 3a ) cells, similar to previous observations, 20, 21 whereas the frequency of irregular DNA contents was greatly increased in DKO thymic lymphomas ( Figure 3a) . Moreover, within each tumor sample, a significantly higher percentage of polyploidy was observed in DKO tumors ( Figure 3b , DKO versus p53 null , P ¼ 0.017, two-tailed Mann-Whitney rank sum test). Cytogenetic analyses with thymic lymphomas from eight DKO and four p53 null mice further confirmed exacerbated genomic instability in DKO tumors: 30% of 50 metaphases examined from the DKO lymphomas maintained diploid chromosome number of 40 ( ¼ 2n), whereas more than 65% of the 50 metaphases from p53 null tumors showed diploid chromosome number (Figure 4a ). More strikingly, over 80% metaphases from DKO tumors contained at least one translocation involving centromeric fusions between the telocentric chromosomes (Robertsonian translocation), among which approximately 40% contained 2-4 translocations/cell (Figure 4b ). In sharp contrast, translocations in tumors from p53 null mice were very rare and none of the metaphases contained two or more translocations per cell (Figure 4b ), similar to previous reports. 20, 21 To further explore other chromosome aberrations in the thymic lymphomas, we employed spectral karyotyping (SKY) analyses. Indeed, DKO tumors frequently showed unbalanced near-triploid chromosome amplification, besides chromosome breaks and non-clonal unbalanced translocations ( Figure 4c and Supplementary Table 3) , whereas chromosome structural aberrations were rarely observed in p53 null tumors (Supplementary Figure S2) . 20, 21 To determine whether chromosome instability is observed prior to tumor development, we karyotyped thymocytes from 4-6-week-old DKO mice before overdevelopment of tumors, defined as aberrant ISP and DP composition via FACS. Indeed, chromosome duplications and fusions were observed in these pre-malignant DKO thymocytes (Supplementary Figure S3A ), indicating that chromosome instability preceded overdevelopment of tumor. To further confirm their lack of early emerging lymphomas, thymocytes of 4-6-week-old DKO mice were also transferred to syngeneic Rag null mice that lacked mature T cells. CD4
þ and CD8 þ mature T cells were observed in the peripheral blood lymphocytes of Rag null mice that received DKO thymocytes over the 3-month period of observation (Supplementary Figure S3B) . These transferred thymocytes did not develop into lymphomas in Rag null mice, like those of ISP or DP phenotypes in the spleen and thymus of DKO mice (Supplementary Figure S3C and Figures 2d and e). Together, these results confirm that genomic abnormality occurred in pre-malignant DKO thymocytes and strongly support the notion that IL-7Ra deficiency in combination with p53 deficiency permits the survival of developing thymocytes and encourages genomic instability, thereby exacerbating lymphomagenesis.
IL-7Ra
null deficiency is associated with telomere dysfunction, which activates DNA damage signals that coincide with telomere signals. Chromosome translocations and fusions can be triggered by various mechanisms, such as T-cell receptor rearrangement, DNA damage-induced double-strand DNA breaks, telomere dysfunction, and DNA repair defects. 10, 18, 20, 22, 23 Robertsonian translocations frequently occur in cells incurring telomere dysfunction. 22, 24 We, therefore, hypothesized that IL-7Ra null results in telomere dysfunction leading to the exacerbated lymphomagenesis in DKO mice. Telomeric fluorescence in situ hybridization (Telo-FISH) revealed complete loss of telomeres at the centromeric fusions of all Robertsonian translocations and some of non-fused chromosomes in DKO lymphomas (Figure 5a ), whereas no obvious telomere loss was observed in p53 null tumors (Figure 5a ). Telo-FISH analyses with fresh unmanipulated thymocytes from 4-6-week-old DKO and p53 null mice IL-7Ra null and telomere dysfunction R Kibe et al confirmed that telomere dysfunction occurred in pre-malignant DKO thymocytes as multi-telomere loss (up to 3/metaphase) in about 27% thymocytes examined as compared with the occasional (7%) undetectable telomeres (not 41/metaphase) in p53 null thymocytes (Figure 5b ). Likewise, Telo-FISH analysis on fresh IL-7Ra null thymocytes also confirmed the frequent loss of telomeres and an overall reduction in the intensity of telomere hybridization signals (Supplementary Figure S4) . Because of the difficulty in obtaining sufficient number of metaphases from IL-7Ra null thymocytes, we employed a flow cytometry-based analysis of Telo-FISH signal (Flow-FISH) to determine the mean fluorescence intensity of telomere signals of cells that possessed identical DNA content determined by propidium iodide staining. As shown in Figure 5c , Flow-FISH analyses confirmed that telomere signals of IL-7Ra null and DKO thymocytes were significantly reduced compared with those of WT and p53 null thymocytes with identical DNA content of 2n, which were G 0 /G 1 phase cells. These results demonstrate that developing thymocytes fail to maintain telomere integrity in the absence of IL-7Ra.
Telomere dysfunction, either via telomere uncapping or shortening, is sensed as double-strand DNA breaks, which trigger DNA damage responses and activate the checkpoint pathways. 19, [25] [26] [27] Consequently, these lead to the localization of DNA damage response factors, such as gH2AX and 53BP1, at the site of dysfunctional telomeres called telomere-induced null mice was determined via FACS. Differences between the two groups were compared (two-tailed Mann-Whitney rank sum test, P ¼ 0.017). The line within each box represents group median, whereas the upper and lower box boundaries mark the 25th and 75th percentiles, and error bars represent the 10th and 90th percentiles DNA damage foci (TIF). 25, 27, 28 To validate the effects of IL-7Ra null in inducing telomere dysfunction, we examined TIFs in IL-7Ra null and DKO thymocytes by immunofluorescence staining of gH2AX followed by Telo-FISH (immunofluoresent fluorescence in situ hybridization (IF-FISH) ). Confocal microscopic image analyses of 450 thymocytes from each genotype revealed that over 70% of IL-7Ra null and DKO thymocytes incurred 44 TIF/cell, whereas only 15-30% of WT and p53 null thymocytes contained 44 TIF/cell (Figure 5d ). In contrast, irradiated WT thymocytes did not show distinct TIFs despite a massive upregulation of gH2AX induced by the irradiation (Supplementary Figure S5) . Among the thymocytes examined, not all DNA damage signals colocalized with telomeres, suggesting the existence of other DNA damages during thymopoiesis (Figure 5d ). To verify that IL-7/IL-7Ra signaling withdrawal caused the increases in TIF, we performed IF-FISH analysis using an established IL-7-dependent p53 null thymic cell line D1Bcl2 that was resistant to apoptosis because of constitutive expression of Bcl2. 29, 30 IL-7 withdrawal from D1Bcl2 cells resulted in cell cycle arrest within 24 h without apparent induction of apoptosis up to 72 h. 30 However, it greatly enhanced the DNA damage signals Figure 4 Genomic instability in DKO thymic lymphomas is further exemplified by marked chromosomal numerical and structural aberrations. Fresh thymic lymphomas harvested from DKO and p53 null mice were prepared for cytogenetic analyses. (a) Frequency of diploidy (2n), tetraploidy (4n), and aneuploidy (o2n, 42n to o4n, and 44n) among 50 metaphases from eight DKO tumors and 50 metaphases from four p53 null tumors was analyzed and summarized. (b) Representative G-band karyotyping images of metaphase preparation reveal Robertsonian translocations, that is, chromosome centromeric fusions (red asterisks), in DKO tumors (left panels). Images were captured using an Applied Imaging ER-3339 cooled CCD camera (ASI) mounted on top of a Nikon Eclipse E400 with CytoVision 3.1 software (ASI). n denotes the total chromosome number, whereas T indicates Robertsonian translocations. The frequency of Robertsonian translocations observed among the 50 metaphases of each tumor type was summarized in the right panel. Each experiment is repeated at least five times involving 5-8 tumors of each genotype. (c) Representative SKY images of DKO lymphoma illustrate numerical and structural anomalies of the chromosomes associated with unbalanced chromosome amplification, breaks (white asterisks), and fusions (yellow asterisks). Images were acquired using a SD301 SpectraCubeTM system (ASI) mounted on top of an epifluorescence microscope Axioplan 2 (Zeiss) and analyzed using Spectral Imaging 4.0 acquisition software (ASI). G banding was simulated by electronic inversion of DAPI counterstaining null and telomere dysfunction R Kibe et al revealed by co-staining with anti-gH2AX and 53BP1 antibodies, the majority of which also colocalized with telomeres as TIFs (Figure 5e ). Together, these results strongly suggest that the lack of IL-7/IL-7Ra signaling in developing thymocytes leads to telomere dysfunction, which triggers DNA damage responses, activates the p53 pathway, and induces apoptosis. Genetic deletion of p53 allows the survival of those thymocytes-accruing telomere dysfunction, DNA damages, and chromosome abnormalities, which initiate and mark the early transition towards tumorigenesis.
IL-7 signaling blockade in p53 null D1 cell line recapitulates telomere dysfunction and chromosomal anomalies observed in DKO lymphomas. To recapitulate our in vivo results of the telomere dysfunction and genomic instability observed in DKO thymocytes, we analyzed telomere signals at various time points after IL-7 withdrawal from D1 cells via Flow-FISH. As expected, IL-7 withdrawal resulted in a significant reduction (B25%) in telomere signal at as early as 16 h (Figure 6a ). At 20-24 h after IL-7 withdrawal, the telomere signal was reduced by about 50%, leading to a complete loss of telomere signal and apoptosis by 30-40 h (Figure 6a ). To verify that the observed drastic reduction in telomere signals via Flow-FISH reflected telomere shortening, we assessed telomere length by Southern blot analysis of terminal restriction fragments (TRFs) (Figure 6b ). Similar to Flow-FISH results, IL-7 withdrawal from D1 cells resulted in a reduction of telomere length to 18.3 Kb within 16 h from 32 Kb and a further decrease to 12.7 Kb by 20 h post-IL-7 withdrawal (Figure 6b ). Together, these results confirm that IL-7 withdrawal results in telomere erosion and genomic instability in IL-7-dependent thymocytes.
As IL-7 withdrawal from D1 cells induced rapid apoptosis in 30-40 h, which prevented us from examining chromosome abnormalities induced by gradual or partial IL-7 withdrawal (Supplementary Figure S6A) , we explored whether an appropriate dose of a JAK3 inhibitor could block D1 proliferation with minimal induction of apoptosis. JAK3 inhibitor VI blocked the IL-7-mediated proliferation at 2 mM without inducing massive apoptosis during the first 40 h (Supplementary Figure S6 ). DNA content analyses revealed that the JAK3 inhibitor treatment induced a G 2 /M phase cell cycle arrest and a marked increase in polyploidy (44n) to 10-20% as compared with a o0.5% polyploidy in untreated D1 cells (Figure 6c ). Further examination on chromosome integrity via karyotyping and Telo-FISH confirmed that 10-20% of the cells became polyploid, possessing diplo-and quadruple-chromosomes by 40 h of the JAK3 inhibitor treatment (Figures 6d and e) . Strikingly, this observed chromosome numerical abnormality was also associated with telomere attrition, chromosome breaks, Robertsonian translocations (Figure 6e, inserts) , and reminiscence of the abnormalities observed in our DKO thymic lymphomas. Altogether, these results strongly support the notion that IL-7Ra deficiency results in telomere dysfunction, which leads to chromosome abnormalities in p53 null cells.
IL-7/IL-7Ra signaling protects telomeres by maintaining protein synthesis of POT1. Telomeres are protected by a specialized protein complex shelterin, consisting of TRF1 (telomeric repeat binding factor 1 or TERF1), TRF2, TIN2 (TERF1-interacting nuclear factor 2), TPP1 (or adrenocortical dysplasia protein homolog), repressor activator protein 1, and POT1. 26 Deficiency in either TRF2 or POT1, which binds double-strand or single-strand telomeric DNA, respectively, induces telomere dysfunction that activates DNA damage signals and the p53 pathway. 26, 31, 32 Therefore, we explored the effects of IL-7 withdrawal from D1 cells on shelterin subunits. Intriguingly, at 20 h post-IL-7 withdrawal, POT1 protein expression was greatly diminished, associated with an elevated gH2AX (Figure 7a ). The level of TPP1 was modestly reduced. However, the expression of other shelterin subunits TFR1, TRF2, and TIN2 was unaffected by the IL-7 withdrawal (Figure 7a ). Similar reduction of POT1 expression also occurred in vivo in IL-7Ra null thymocytes as compared with that of WT thymocytes (Figure 7b ). Only modest reduction in the expression of TPP1, TRF2, and TIN2 was observed, whereas that of TRF1 and repressor activator protein 1 was unaffected in IL-7Ra null thymocytes (Figure 7b ). Further, kinetic analyses upon IL-7 withdrawal demonstrated an inverse correlation between the levels of POT1 and gH2AX in D1 cells (Figure 7c) . Similarly, the Jak3 inhibitor greatly suppressed IL-7-mediated STAT5 phosphorylation and POT1 expression, but not that of TIN2, with a concomitant increase in gH2AX (Figure 7d ). These results strongly suggest that IL-7/IL-7Ra signaling is essential for proper POT1 expression and the maintenance of telomere integrity in IL-7-dependent cells.
To better understand the regulatory mechanism of POT1 by IL-7, we examined the mRNA levels of both POT1a and POT1b, two murine orthologs, in D1 cells upon IL-7 withdrawal and found that neither RNA transcript was affected (Supplementary Figure S7) . As POT1a and POT1b proteins have an identical molecular size and the antibody we used does not distinguish these two proteins, our analyses on POT1 protein were not meant to discriminate them. We examined whether POT1 protein stability was affected by the IL-7/IL-7Ra signaling in D1 cells in the presence of a protein synthesis inhibitor cycloheximide. However, the presence or absence of IL-7 did not alter the kinetics of POT1 degradation in D1 cells (Supplementary Figure S8) , suggesting that IL-7 signaling did not regulate POT1 protein stability. To further determine whether POT1 protein synthesis was altered in the absence of IL-7, we performed metabolic labeling upon IL-7 withdrawal and found that the level of newly synthesized POT1, measured by the 35 S-Methoinine labeling, was greatly diminished within 12 h of IL-7 withdrawal (Figure 7E ), indicating that IL-7 regulates POT1 at the protein synthesis level. Finally, to test whether enforced expression of either POT1a or POT1b would rescue the telomere attrition by IL-7 withdrawal in D1 cells, we subjected D1Bcl2 cells overexpressing POT1a or POT1b to IL-7 withdrawal. Interestingly, either POT1a or POT1b alone did not prevent IL-7 withdrawalinduced telomere attrition, but co-expression of POT1a and POT1b prevented the telomere loss induced by IL-7 withdrawal ( Figure 7F ). Taken together, these results strongly suggest that IL-7/IL-7Ra signaling protects telomere integrity by maintaining POT1expression at the protein synthesis level in both IL-7-dependent D1 cells and primary thymocytes.
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Discussion
Our study reveals a previously unappreciated interaction between IL-7/IL-7Ra signaling and the p53 pathway, as well as the crucial role of IL-7/IL-7Ra in maintaining genomic stability during thymopoiesis. We demonstrate that in the absence of IL-7/IL7Ra signaling, IL-7-dependent cells fail to maintain POT1 protein synthesis and telomere integrity, leading to rapid telomere attrition, activation of DNA damage Recent evidence demonstrates that POT1 is essential for protecting telomeres from rapid degradation. [31] [32] [33] Our study is the first that demonstrates the essential role of POT1 in cytokine-mediated T-cell development by suppressing telomeric DNA damage signals. Although the consequence of POT1 null to T-cell development is not previously documented because of embryonic lethality of POT1a null mice, the observed chromosome abnormalities in our DKO thymic lymphomas are similar to those reported in mouse embryonic fibroblasts lacking POT1a/b, especially those with simultaneous inactivation of p53. 32, 33 Our results with ectopic expression of POT1a/b in D1 cells and those of the abovereferenced reports of POT1a/b null mouse embryonic fibroblast strongly suggest that both POT1a and POT1b are required to prevent telomeric DNA damage signals and the loss of both promotes polyploidy, chromosome fusions, and breaks. 32, 33 Moreover, our study also suggests that IL-7 regulates POT1 expression at the protein synthesis level via the JAK3-STAT5 pathway because JAK3 inhibitor treatment of D1 cells suppresses POT1 expression and mimics chromosome abnormalities incurred in DKO lymphomas. This notion also agrees with a previous report on JAK3 inhibitor-induced endoreduplication in leukemia cells. 34 Nevertheless, IL-7 deficiency-induced telomere dysfunction as rapid telomere erosion in D1 cells, and IL-7Ra null and DKO thymocytes was not reported in POT1a/b null mouse embryonic fibroblast. 32, 33 The differences between our study and previous observations are likely related to the cellular context, that is, intrinsic properties of different cell type and the potential contribution of other IL-7-dependent effects, which will be investigated in future studies.
Recent observations reveal that about 10% T-cell acute lymphoblastic leukemia carry gain-of-function mutations of IL-7Ra gene, which promote oncogenic transformation via constitutive activation of JAK1, but not JAK3. 35, 36 Nevertheless, this T-cell acute lymphoblastic leukemia is not linked to poor prognosis, 35, 36 suggesting a different tumorigenic process from that of our DKO mice. As IL-7Ra deficiency causes lymphopenia, which was modestly improved in DKO mice by p53 inactivation but to a lesser extent than that by Bcl2 overexpression, [5] [6] [7] it is also plausible to propose that the lymphopenia environment promotes vigorous compensatory proliferation of stem cells and progenitors, and encourages accrued mutations and genomic instability, thereby enhancing their risk of oncogenesis like those observed in recent studies. 37, 38 Therefore, IL-7 signaling should be exquisitely controlled to ensure proper thymopoiesis while preventing lymphomagenesis.
In summary, this is the first study illustrating the functional interplay of the IL-7Ra signaling with the p53 pathway in maintaining genomic stability during thymopoiesis. Our study underscores a novel function of IL-7Ra signaling during thymopoiesis in maintaining POT1 expression and telomere integrity, which may shed light on future studies on immune deficiency and lymphomagenesis. Moreover, this DKO mouse may represent a unique model for studying cytokine withdrawal-induced chromosome instability in tumorigenesis.
Materials and Methods
Mice. DKO mice were generated by intercrossing IL-7Ra null (B6 129S7-Il7r tm1Imx /J) p53 null mice for more than five generations. All mice, including Rag1 null (B6.129S7-Rag1 tm1Mom /J), were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). All mice were bred and kept under specific pathogen-free conditions in the animal care facility of LSUHSC following protocols approved by the Institutional Animal Care and Use Committee. Genotypes were confirmed by PCR.
Cell lines and retroviral transduction. The IL-7-dependent thymocyte cell line D1 established from p53 KO mice were maintained in RPMI 1640 supplemented with 10% fetal bovine serum (Sigma, St. Louis, MO, USA), 2 mM Lglutamine, 50 mM b-mercaptoethanol (Invitrogen, Carlsbad, CA, USA), and 50 mg/ ml murine recombinant IL-7 (PeproTech, Rocky Hill, NJ, USA). The D1 cells were treated with 2 mM JAK3 inhibitor VI (EMD Biosciences, Darmstadt, Germany) for various durations in the presence of 50 mg/ml IL-7. D1 or D1Bcl2 cells were transduced with retroviruses pLPCN-MycPOT1a, pLPCN-MycPOT1b (kindly provided by Dr. Titia de Lange), or both and selected with puromycin (5 mg/ml) in the presence of IL-7 for 7 days. null thymic cells D1Bcl2 cultured in the presence or absence of IL-7 were co-immunostained with rabbit anti-g H2AX-Alexa568 and mouse anti-53BP1-Alexa647 followed by Telo-FISH hybridization with FAM-labeled PNA probe. Representative confocal microscopic deconvolved single-plan images showing IL-7 withdrawal induced DNA damage signals by both g H2AX and 53BP1 (pseudo colored red) within the same cell were merged with telomere signals (green) to demonstrate the TIF (yellow). DNA was counterstained with DAPI (blue). Scale bars ¼ 2 mm. Arrowheads indicate TIFs, whereas enlarged images of TIFs from the dashed boxes are presented to the right as separate panels of DNA damage and telomere signals, as well as merged images null and telomere dysfunction R Kibe et al Flow cytometry analysis. All antibodies for FACS analyses were purchased from BD Biosciences (San Jose, CA, USA), unless otherwise specified. Thymocytes and thymic lymphomas were harvested and processed to make single-cell suspensions for cell-surface marker analysis. Flow cytometric acquisition was performed using a FACSCalibur (BD Biosciences) and analyzed using FlowJo software (Tree Star Inc., Ashland, OR, USA). . Fresh thymocytes in single-cell suspension were first stained for cell-surface markers and fixed in cold 70% EtOH at À201C for 4 h. They were subsequently stained with rabbit anti-p53 ser18 antibody (100 Â dilution; Cell Signaling Technology, Boston, MA, USA) and PEconjugated goat anti-rabbit antibody in FACS buffer (PBS containing 2 mM EDTA, 2% FBS, and 0.01% sodium azide) in the presence of phosphatase inhibitor (EMD Chemicals, San Diego, CA, USA) at 41C. The level of p53 ser18 signal was determined via FACS.
IL-
Tumorigenesis and pathological analyses. Cohorts of 26-36 mice/ genotype were observed for tumor development. A portion of the tumors was preserved in buffered zinc formalin fixative (Anatech Ltd, Battle Creek, MI, USA), and sectioned for H&E staining. The other portion of the tumors was dissociated to single-cell suspension for surface marker staining and FACS analysis. H&E sections were viewed by a licensed pathologist to determine the tumor type in reference to their cell-surface marker expression and anatomic location of the tumors. S-Methionine were immunoprecipitated with antibodies against POT1 or b-actin and were subjected to electrophoresis and autoradiography. All experiments were repeated at least three times with similar results. (f) D1Bcl2 cells retrovirally transduced with POT1a or POT1b, or both POT1a and POT1b were selected by puromycin for 7 days and subjected to IL-7 withdrawal. At 20 h after IL-7 removal, their telomere hybridization signal was determined via Flow-FISH and compared with those cultured in the present of IL-7. Data is presented as mean ± s.e. of three independent experiments 
